Ill-gotten gains – Economic Disincentives for Trusting Science 
August 10, 2022

Alleged academic fraud in a prominent Alzheimers research paper and a new umbrella study on the effectiveness of antidepressants have opened a discussion concerning the modern approach to pharmaceutical research and development. Join Morgan as he highlights the economic factors which underpin the industry and the importance of innovation in addressing these recent challenges.


The CAINZ Digest is published by CAINZ, a student society affiliated with the Faculty of Business at the University of Melbourne. Opinions published are not necessarily those of the publishers, printers or editors. CAINZ and the University of Melbourne do not accept any responsibility for the accuracy of information contained in the publication.